DEFA14A: Brookdale Senior Living Defends Strategic Turnaround and Board Leadership Amid Activist Shareholder Challenge
Definitive Proxy Statement
Brookdale Senior Living Inc. has issued a definitive proxy statement defending its current board composition and strategic initiatives against a control contest by ~1% shareholder Ortelius, while detailing significant operational improvements and its ongoing CEO succession plan.
Summary
- Brookdale Senior Living is the largest senior living operator in the U.S., managing 647 geographically diverse communities across 41 states, serving approximately 58,000 senior residents.
- The company's Q125 portfolio mix consists of 61% owned, 31% leased, and 8% managed units, with a strategic focus on increasing its owned asset base to 75% by year-end 2025.
- The Board initiated a CEO succession plan in November 2024, leading to the transition of the former CEO in April 2025, with Denise Warren appointed as Interim CEO.
- The Board has undergone significant refreshment, with four new independent directors appointed in the past 12 months, resulting in seven of eight nominees being independent and an average tenure of less than 4 years.
- Brookdale asserts that Ortelius, a ~1% shareholder, is seeking control of the Board and proposing strategic actions that are largely already underway, potentially undermining the company's progress and delaying the CEO search.
- Since 2022, Brookdale has renegotiated leases for approximately 250 communities, resulting in the leased portfolio becoming Adjusted Free Cash Flow positive.
- The company has reduced its leased units by 19% (4,054 units) since Q121 and expects a further reduction of ~30% (6,125 units) in 2025, aiming for a ~50% reduction since Q121 by year-end.
- Lease renegotiations since 2022 have secured approximately $140 million in landlord-funded capital expenditures for property reinvestment.
- Operational improvements led to positive Adjusted Free Cash Flow in the second half of 2024, with Q125 Adjusted Free Cash Flow at $3.8 million (up $30 million YoY) and an annual midpoint guidance of $40 million for 2025.
- Q125 Adjusted EBITDA increased 27% year-over-year and is up approximately 255% from Q121, with the 2025 midpoint guidance increased by $7.5 million.
- The company's leverage ratio has been reduced by nearly half over the prior two-year fiscal period, achieving approximately 10x annualized leverage reduction since pandemic highs of 2022.
- Same community weighted average occupancy rates have grown to 80.6% in May 2025, up from a pandemic low of 69.4% in March 2021.
- Brookdale HealthPlus, an innovative care delivery model, has improved resident outcomes, resulting in 80% fewer urgent care visits and 66% fewer hospitalizations, and is expected to be in nearly 190 communities by year-end 2025.
- The real estate portfolio has been strategically reduced from over 1,000 communities in 2017 to less than 600 by year-end 2025.
Sentiment
Score: 8
Explanation: The document presents a highly positive outlook, emphasizing significant operational and financial improvements post-COVID, including positive free cash flow, increased occupancy, and reduced leverage. It strongly defends the company's current strategy and board against an activist challenge, positioning Brookdale as successfully executing its plan and well-positioned for future growth, despite the ongoing proxy contest.
Positives
- Brookdale is the largest senior living operator in the U.S. with unmatched scale, geographic footprint, and nearly 50 years of operating experience.
- The company demonstrates strong operational expertise, with approximately 10% of its workforce being nurses focused on evidence-based clinical practices.
- The Brookdale HealthPlus program has significantly improved resident outcomes, leading to 80% fewer urgent care visits and 66% fewer hospitalizations.
- Successful execution of strategic initiatives has streamlined operations, rationalized the lease portfolio, and reduced leverage.
- The leased portfolio is now Adjusted Free Cash Flow positive and is expected to contribute meaningfully to future operations.
- Significant reduction in leased units (19% since Q121, with a target of ~50% reduction by year-end 2025) enhances financial performance.
- The company has secured substantial landlord-funded capital expenditures (approximately $140 million since 2022) for property reinvestment.
- Adjusted Free Cash Flow turned positive in H2 2024 and Q125 ($3.8 million), with a positive annual midpoint guidance of $40 million for 2025.
- Strong Adjusted EBITDA growth of 27% year-over-year in Q125 and approximately 255% from Q121, with increased guidance for 2025.
- Leverage ratio has been significantly reduced by nearly half over the prior two-year fiscal period, improving financial resilience.
- Occupancy rates have shown robust recovery, growing to 80.6% in May 2025 from a pandemic low of 69.4% in March 2021.
- The Board has undergone a thoughtful refreshment process, adding highly qualified independent directors with relevant expertise in healthcare, hospitality, operations, and real estate.
- Brookdale has outperformed Sonida Senior Living, its closest comparable, in stock performance across most measured timeframes (6-year, 3-year, 1-year, YTD25).
- Executive pay is tightly aligned with performance, featuring a clawback policy and robust stock ownership guidelines.
- The senior living market is supported by powerful demographic tailwinds, including a growing 75+ population and new construction lagging demand, creating favorable market dynamics for pricing and occupancy growth.
- Brookdale's portfolio is well-structured with a high private pay mix (approximately 98% of revenue), minimizing government reimbursement risk.
Negatives
- The disruptive campaign by Ortelius, a ~1% shareholder, has delayed the CEO search process.
- Ortelius refused to engage meaningfully with the company for nearly two months after nominating a control slate, hindering constructive dialogue.
- Ortelius's proposed strategic actions are largely already underway, suggesting a lack of unique value proposition.
- Ortelius's director nominees predominantly possess real estate backgrounds, which are already well-represented on the current board, and lack critical skillsets in clinical healthcare, hospitality, and sales & marketing.
- The COVID-19 pandemic significantly impacted the senior living industry, causing widespread occupancy declines, rising labor and personal protective equipment costs, and operational disruptions.
- Brookdale's higher mix of Assisted Living and Memory Care residents meant it suffered more than some peers during the COVID-19 pandemic due to higher acuity levels.
- Legacy leases previously led to pressure on margins and growth, although the company has taken significant actions to reorganize its leased portfolio.
Risks
- Events that adversely affect the ability of seniors to afford resident fees, including downturns in the economy, housing market, consumer confidence, or equity markets, and unemployment among resident family members.
- The effects of senior housing construction and development, lower industry occupancy, and increased competition.
- Conditions of housing markets, regulatory changes, acts of nature, and the effects of climate change in geographic areas where the company is concentrated.
- Terminations of resident agreements and vacancies in leased living spaces.
- Changes in reimbursement rates, methods, or timing under governmental reimbursement programs, including Medicare and Medicaid.
- Failure to maintain the security and functionality of information systems, prevent cybersecurity attacks or breaches, or comply with applicable privacy and consumer protection laws, including HIPAA.
- The company's ability to complete its capital expenditures in accordance with its plans.
- The company's ability to identify and pursue development, investment, and acquisition opportunities and successfully integrate acquisitions.
- Competition for the acquisition of assets.
- The company's ability to complete pending or expected disposition, acquisition, or other transactions on agreed-upon terms or at all, including satisfaction of closing conditions and regulatory approvals.
- Risks related to the implementation of the company's strategy, including initiatives undertaken to execute on strategic priorities and their effect on results.
- Any resurgence or variants of the COVID-19 pandemic.
- Limits on the company's ability to use net operating loss carryovers to reduce future tax payments.
- Delays in obtaining regulatory approvals.
- Risks associated with tariffs and the uncertain duration of trade conflicts.
- Disruptions in the financial markets or decreases in the appraised values or performance of communities that affect the company's ability to obtain financing or extend or refinance debt as it matures, and financing costs.
- The company's ability to generate sufficient cash flow to cover required interest, principal, and long-term lease payments and to fund planned capital projects.
- The effect of any non-compliance with any of the company's debt or lease agreements (including financial or other covenants), including the risk of cross-defaults and loss of property.
- The inability to renew, restructure, or extend leases, or exercise purchase options at or prior to the end of any existing lease term.
- The effect of the company's indebtedness and long-term leases on its liquidity and ability to operate its business.
- Increases in market interest rates that increase the costs of debt obligations.
- The company's ability to obtain additional capital on terms acceptable to it.
- Departures of key officers and potential disruption caused by changes in management.
- Increased competition for, or a shortage of, associates, wage pressures, minimum wage increases, changes in overtime laws, and union activity.
- Environmental contamination at any communities or failure to comply with existing environmental laws.
- An adverse determination or resolution of complaints filed against the company, including putative class action complaints.
- Negative publicity with respect to any lawsuits, claims, or other legal or regulatory proceedings.
- Costs to respond to, and adverse determinations resulting from, government inquiries, reviews, audits, and investigations.
- The cost and difficulty of complying with increasing and evolving regulation, including new disclosure obligations.
- Changes in, or failure to comply with, employment-related laws and regulations.
- Risks associated with current global economic conditions and general economic factors such as inflation, commodity costs, fuel and other energy costs, competition in the labor market, costs of salaries, wages, benefits, and insurance, interest rates, tax rates, tariffs, geopolitical tensions or conflicts, and uncertainty surrounding a new presidential administration, and the impact of seasonal contagious illness or other contagious disease.
- Actions of activist stockholders, including as a result of the current proxy contest and any potential change of control of the company or the Board.
Future Outlook
Brookdale is strategically positioned to capitalize on the operating leverage of its high fixed cost business, with robust demographic and industry tailwinds expected to deliver compelling and sustainable shareholder returns. The leased portfolio is projected to be meaningfully Adjusted Free Cash Flow positive in 2025, with an annual midpoint guidance of $40 million. By year-end 2025, the company anticipates further optimizing its real estate portfolio by exiting 55 leased communities and divesting 14 non-core owned communities, while also evaluating additional assets for disposition. Planned capital expenditures for 2025 are set between $175 million and $180 million, and the majority of the company's debt is refinanced through the end of 2026. A 10% increase in Adjusted EBITDA is expected to result in approximately 1x annualized leverage reduction. The Brookdale HealthPlus program is projected to expand to nearly 190 communities by year-end 2025, enhancing resident health outcomes. The company expects continued improvements in resident satisfaction and operational excellence through expanded programming and enhanced associate engagement and retention. Further occupancy recovery to a pre-pandemic rate of 84.5% is estimated to yield $170 million in incremental revenue and $125 million in incremental operating income. The senior living market is expected to benefit from supportive demographic trends, particularly the growing 75+ population, and favorable supply-demand dynamics where new construction lags demand, creating potential for additional pricing growth and a floor for future occupancy levels.
Management Comments
- "Brookdale is a Unique Senior Living Provider Combining Unmatched Scale, Purpose-Driven Care, and Operational Expertise."
- "Brookdale Senior Living Is Well-Positioned and Is Successfully Executing its Strategy Positioned to Deliver Meaningful Shareholder Value."
- "The Board and management are executing on five key initiatives to deliver meaningful shareholder value – improving operating performance, optimizing real estate portfolio, reinvesting capital into communities, reducing leverage, and ensuring high-quality environments for residents and associates."
- "The Board transitioned the Company’s former CEO in April 2025 upon receiving feedback from shareholders that immediate management change was preferred."
- "The Board is interviewing CEO candidates now; originally, Brookdale had hoped to find a new CEO by June 2025."
- "Ortelius disruptive campaign delayed the CEO search process."
- "The Board seeks a CEO who will be focused on driving continued operational and financial improvements, capitalizing on the intrinsic value of our owned real estate portfolio and leveraging our compelling industry dynamics and cash flow generation potential."
- "Our enthusiasm about Brookdale’s future has never been greater and we support the Board’s efforts to extend Brookdale’s leadership in patient care and financial performance. We look forward to supporting Brookdale as it brings new talent and energy to the Board and executive team." (Quoting Deerfield Management, a significant stockholder)
Industry Context
The senior living industry is characterized by a unique blend of hospitality, real estate, and healthcare services. It is a large and growing market, primarily fueled by supportive demographic trends, specifically the accelerating growth of the 75+ population, which is outpacing other demographic groups. This demographic shift, coupled with new construction lagging demand, creates favorable supply-demand dynamics that are expected to drive increased demand and potential pricing growth for senior living services. The high-income senior population is identified as the fastest-growing segment, enhancing the ability of residents to pay for services. While the COVID-19 pandemic significantly impacted the industry, causing widespread occupancy declines and increased operational costs (labor, PPE), the broader healthcare services sector has demonstrated resilience in volatile market environments. The document highlights that senior living, particularly Assisted Living (AL) and Memory Care (MC), is well-positioned for continued growth due to the increasing prevalence of chronic conditions, which necessitates higher acuity care. The industry also benefits from a predominantly private pay model (approximately 98% of Brookdale's revenue), which minimizes exposure to government reimbursement risks.
Comparison to Industry Standards
- Brookdale is recognized as the #1 Senior Living Operator in the U.S. by number of units under operations, as reported by the American Seniors Housing Association in the 2024 ASHA 50 report.
- The average tenure of Brookdale's Board of Directors is less than 4 years, which is significantly below the S&P 500 average of approximately 8 years, indicating a commitment to board refreshment.
- Brookdale's Net Operating Income (NOI) margin growth is in line with peers such as Sonida Senior Living, Welltower Inc., Ventas, Inc., and American Healthcare REIT, despite Brookdale's higher concentration in Assisted Living (AL) and Memory Care (MC) segments.
- Brookdale's Adjusted EBITDA margins have rebounded to pre-COVID levels, contrasting with still-depressed levels for Sonida Senior Living, which is identified as the closest comparable publicly traded senior living operating company.
- Brookdale's occupancy growth over the past three years is consistent with the industry average and has outperformed the Ventas Senior Housing Operating Portfolio (SHOP).
- In stock performance, Brookdale outperformed Sonida Senior Living over the 6-year (+5.3% vs. -51.7%), 3-year (+12.8% vs. -5.2%), 1-year (-2.1% vs. -11.8%), and YTD25 (+29.4% vs. +5.7%) periods. However, Sonida outperformed Brookdale over the 5-year (+163.3% vs. +77.9%) and 2-year (+239.0% vs. +89.8%) periods.
- Welltower and Ventas are deemed not to be perfect comparables due to their REIT structure, significantly larger market capitalizations ($101 billion and $29 billion respectively), diversified healthcare real estate portfolios (not solely senior living), and lower cost of capital compared to Brookdale.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Former CEO | Cindy Baier | Denise Warren (Interim CEO) | April 2025 | Shareholder feedback indicated immediate management change was preferred. |
| Independent Director | Elizabeth Mace | June 2024 | Part of the Board refreshment process to bring fresh perspectives and relevant expertise. | |
| Independent Director | Claudia Drayton | June 2024 | Part of the Board refreshment process to bring fresh perspectives and relevant expertise. | |
| Independent Director | Mark Fioravanti | April 2025 | Part of the Board refreshment process to bring fresh perspectives and relevant expertise. | |
| Independent Director | Joshua Hausman | April 2025 | Part of the Board refreshment process to bring fresh perspectives and relevant expertise. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition/Refreshment | Four new independent directors (Elizabeth Mace, Claudia Drayton, Mark Fioravanti, Joshua Hausman) appointed in the past 12 months. If Brookdale's nominees are elected, the Board will consist of eight directors, seven of whom are independent, with an average tenure of less than 4 years. | June 2024 (Mace, Drayton), April 2025 (Fioravanti, Hausman) | Aims to balance fresh perspectives with institutional knowledge, driving greater accountability and aligning with shareholder interests by bringing diverse and critical skillsets to the boardroom. |
| CEO Leadership Structure | Transitioned former CEO, with Denise Warren stepping in as Interim CEO in addition to her role as Chair. The Board is actively seeking a permanent CEO and will reassess its leadership structure upon identification of a new CEO. | April 2025 | Addresses shareholder feedback for immediate management change and positions the company for its next phase of leadership, ensuring continuity during the search for a permanent CEO. |
| Director Election Policy | Annual elections of all directors (no classified Board). | Ongoing | Promotes greater accountability of directors to shareholders and enhances shareholder influence over board composition. |
| Voting Standard | Majority vote standard for non-contested director elections. | Ongoing | Strengthens shareholder democracy by requiring directors to receive majority support from votes cast. |
| Shareholder Rights Plan | No stockholder rights plan (poison pill). | Ongoing | Avoids anti-takeover measures that could entrench management and dilute shareholder value, promoting a more open market for corporate control. |
| Hedging and Pledging Policy | Policy against hedging and pledging of securities by insiders. | Ongoing | Ensures that the financial interests of directors and executive officers are fully aligned with the long-term interests of all shareholders. |
| Compensation Alignment | Executive compensation is aligned with company performance, with a significant portion of target direct compensation awarded as variable, at-risk compensation. | Ongoing | Incentivizes executives to focus on initiatives that drive growth and increase shareholder value, promoting accountability for financial outcomes. |
| Supermajority Vote Requirement | No supermajority vote required to approve mergers. | Ongoing | Facilitates potential strategic transactions and mergers by preventing a small minority of shareholders from blocking value-creating opportunities. |
| Board Committees | Fully independent Board standing committees. | Ongoing | Enhances independent oversight of critical areas such as audit, compensation, and nominating/corporate governance, fostering stronger corporate accountability. |
| Regular Director Refreshment | The Board engages in regular director refreshment, with six highly-respected independent directors appointed over the last 7 years. | Ongoing | Ensures the Board maintains fresh perspectives and relevant skillsets necessary for overseeing the company's long-term strategy and adapting to industry changes. |
Legal Proceedings
- The company incurs legal costs associated with putative class action litigation.
- There is a risk of adverse determination or resolution of complaints filed against the company, including putative class action complaints.
- The company faces potential costs to respond to, and adverse determinations resulting from, government inquiries, reviews, audits, and investigations.
- Negative publicity may arise with respect to any lawsuits, claims, or other legal or regulatory proceedings.
Stakeholder Impact
- Shareholders: Potential for enhanced value through strategic execution, improved financial performance, and board accountability. However, the ongoing activist campaign introduces uncertainty and potential disruption.
- Residents: Benefit from improved quality of care and services through the Brookdale HealthPlus program, expanded programming, and reinvestment in communities, leading to better health outcomes and satisfaction.
- Employees (Associates): Expected to experience enhanced engagement and retention through development programs and clear career advancement pathways. However, the company faces risks related to increased competition for associates and wage pressures.
- Landlords/Lessors: Impacted by lease renegotiations, which have resulted in some lease terminations and others providing landlord-funded capital expenditures for property improvements.
- Creditors: Benefit from the company's efforts to reduce leverage and refinance debt through the end of 2026, which improves financial resilience and the ability to service outstanding indebtedness.
Next Steps
- The Board is actively looking for a permanent CEO and will reassess its leadership structure once a new CEO is identified.
- Continue to improve operating performance to drive higher occupancy, improve rates, and generate robust cash flow, including bringing underperforming communities to breakeven status.
- Optimize the real estate portfolio by exiting another 55 leased communities and divesting another 14 non-core owned communities by year-end 2025.
- Evaluate the next group of assets for disposition to maximize proceeds.
- Reinvest capital into communities, with $175 million to $180 million planned capital expenditures in 2025.
- Reduce leverage by applying a portion of asset sale proceeds toward debt reduction and through continued Adjusted EBITDA and cash flow growth.
- Expand the HealthPlus clinical offering to nearly 190 communities by 2025 year-end.
- Continue improving resident satisfaction and operational excellence through expanded programming.
- Enhance associate engagement and retention through development programs and career advancement pathways.
- Conduct the 2025 Annual Meeting of Stockholders to solicit proxies for director nominees and other matters.
Key Dates
| Date | Description |
|---|---|
| 2014 | Company began selling or terminating leases on approximately 350 communities that no longer fit its strategic plan. |
| 2018 | Sale of Battery Park complex for $194 million. |
| April 2018 | Restructured a portfolio of 128 communities, combining them into a single master lease. |
| 2019 | Victoria Freed joined the Board of Directors. |
| January 2020 | Acquired 18 previously-leased communities, restructured a remaining 24-community lease, and sold interest in a 14-community unconsolidated CCRC venture. |
| July 2020 | Renegotiated lease in response to COVID, reducing annual rent by $83 million and eliminating some financial covenants. |
| March 2021 | Weighted average occupancy reached a pandemic low of 69.4%. |
| Q121 | Company began reducing leased units, achieving a 19% reduction by Q125. |
| 2022 | Company began renegotiating leases for approximately 250 communities inherited by management and the Board. |
| November 2022 | Offered Tangible Equity Units to raise capital. |
| February 2023 | Amended Master Lease for a portfolio of 35 properties, declining to renew half due to unattractive option rates. |
| May 2023 | Renegotiated Triple-Net Leases with Welltower Joint Venture, securing a $17 million lessor-funded capital expenditure fund. |
| June 2024 | Elizabeth Mace and Claudia Drayton appointed as independent directors to the Board. |
| August 2024 | Amended Master Lease, negotiating $80 million in lessor-funded CapEx through 2037. |
| November 2024 | Board began implementation of CEO succession plan, contacting Spencer Stuart. |
| December 2024 | Renegotiated lease on favorable terms, terminating leases on 55 communities (6,125 units) and securing a $35 million landlord-funded CapEx pool. Last VTR lease renegotiated. |
| April 2025 | Former CEO transitioned, and Denise Warren stepped in as Interim CEO. Mark Fioravanti and Joshua Hausman appointed as independent directors to the Board. |
| May 2025 | Same community weighted average occupancy rate reached 80.6%. |
| May 14, 2025 | Company filed its definitive proxy statement with the SEC. |
| June 2025 | Original target month for finding a new CEO, which was delayed by Ortelius's campaign. |
| 2025 Year-End | Expected completion of exiting another 55 leased communities and divesting another 14 non-core owned communities. Brookdale HealthPlus expected to be in nearly 190 communities. |
| 2026 | Majority of the company's debt is refinanced through the end of this year. |
Recommendation
holdKeywords
Senior Living, Assisted Living, Memory Care, Independent Living, SEC Filing, Proxy Statement, Corporate Governance, Shareholder Activism, Financial Performance, Real Estate, Healthcare, Occupancy Rates, Adjusted EBITDA, Free Cash Flow, Lease Renegotiation, CEO Succession, Risk Management, Brookdale Senior Living, Ortelius
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.